Chris Tyler

Chris Tyler

Chris Tyler, a Wall Street veteran of more than 20 years, began his career in the financial markets working on the trading floor of the AMEX in New York as an equity option market maker at Interactive Brokers’ floor trading unit Timber Hill LLC.

After moving to San Francisco to make markets on the P-Coast exchange during the dot-com craze and spending nearly a decade working in names like Philip Morris, Seagate and Compaq, Chris hung up his smock and trading badge, but not his passion for options and the markets.

Since exiting the floor, and for the better part of the past dozen years, Chris has worked as an option and market strategist, writing analyses for Trading Markets, Charles Schwab subsidiary Optionetics and as a featured columnist at Investor’s Business Daily.

Aside from offering his trading insights at InvestorPlace.com, Chris is currently studying for his Accredited Portfolio Management Advisor (APMA) designation, manages investments for closely held accounts and offers his services as an investment strategist to GLJ Advisors, a CA based RIA.

Chris, his wife and blue heeler live in the Pacific NW. And if you can’t follow him around in your own VW Vanagon or Westfalia, feel free to follow him on Twitter via @Options_CAT.

Recent Articles

3 Second-Shot Covid Stocks to Buy

The way 2022 is shaping up off and on the price charts, investors may consider these three Covid stocks to buy for a healthier portfolio.

Cloudflare Is Running On Borrowed Time

NET stock is a promising growth pick, but Cloudflare is running into some valuation problems that it can't ignore.

Cardano Founder Charles Hoskinson Asks Why You Care About Its Price

Ethereum's co-founder is warning of excesses in cryptos, and a larger bearish phase in Cardano coin doesn't preclude more downside.

Ocugen Needs More Than Covaxin to Boost Its Falling Shares

A doomed-looking vaccine partnership puts Ocugen back in the business of obscurity and OCGN stock at risk of much lower prices.

Is Now the Time to Buy MicroVision Stock?

The jury is still rightfully out in MicroVision, but that doesn't mean investors have to steer clear of MVIS stock completely.